Alexander Bodelier - Concepedia

Author

Alexander Bodelier

Also Known As

A Bodelier, A G Bodelier, A G L Bodelier, A H (Koos) Zwinderman, A. Bodelier, A. G. Bodelier, A. G. L. Bodelier, Alexander Bodelier, Alexander De Bodelier, Alexander G L Bodelier

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Amphia Ziekenhuis Maastricht University University Medical Center Utrecht OLVG Radboud University Medical Center

About

Alexander Bodelier is an author at Amphia Ziekenhuis specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	357
2	Gastroenterology	5	5	213
3	Allergy	1	1	81
4	Hepatology	1	1	144
5	Microbiology	1	1	81

Alexander Bodelier

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study Vince Biemans, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, Journal of Crohn s and Colitis	2019	176
Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial Daisy Walter, Petra G.A. van Boeckel, Marcel J. M. Groenen, Gastroenterology HepatologyBiliary TractMedicineBiliary CancerLumen-apposing Metal Stent	2015	144
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment Vince Biemans, C. Janneke van der Woude, Gerard Dijkstra, Alimentary Pharmacology & Therapeutics	2020	123
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry Vince Biemans, Jasmijn A M Sleutjes, Annemarie C. de Vries, Alimentary Pharmacology & Therapeutics	2020	83
Volatile metabolites in breath strongly correlate with gut microbiome in CD patients Agnieszka Smolinska, Danyta I. Tedjo, Lionel Blanchet, Analytica Chimica Acta DysbiosisHost-microbe InteractionsGastroenterologyGut MicrobiotaMicrobiota Composition	2018	81
Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life Shannon L. Kanis, Sanne Modderman, Johanna C. Escher, Gut	2020	78
Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease Luuk Stapersma, Gertrude van den Brink, Jan van der Ende, International Journal of Behavioral Medicine	2019	70
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study Lauranne Derikx, Marten A. Lantinga, Dirk J. de Jong, Journal of Crohn s and Colitis	2020	70
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial Anne S. Strik, Wim van de Vrie, Joanne P J Bloemsaat-Minekus, The Lancet. Gastroenterology & hepatology InflammationBiosimilar Ct-p13Originator InfliximabGastroenterologyClinical Trials	2018	62
Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohnʼs Disease Alexander Bodelier, Agnieszka Smolinska, Agnieszka Barańska, Inflammatory Bowel Diseases	2015	61

Page 1